Published: Nov 22, 2013
Author: BioCeuticals - Editor
The efficacy of any therapeutic agent is based upon delivering an effective dose. This is especially relevant when we look at curcumin. Curcumin has been the subject of almost 3000 pre-clinical investigations. It has been suggested to have the ability to inhibit the action of inflammatory mediators. The problem lies with the fact that curcumin is a very poorly absorbed compound. Trying to achieve therapeutic concentrations is very difficult. Numerous technologies have been developed over the years, but the reality is, none have come close to achieving the bioavailability of Theracurmin.
Theracurmin is manufactured from the highest quality curcumin extract, as indicated by its brilliant yellow colour. Then, through a process known as “wet mill grinding” the particle size is reduced so that it is 100 times smaller than regular curcumin powder. It is then encapsulated in a vegetable gum to form a colloid suspension. This allows Theracurmin to disperse evenly throughout a solution and is the reason for its vastly superior bioavailability.
Watch this short video and see why Theracurmin is far superior to any other form of curcumin on the market, without question.